IMUX FY 2017 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena

IMUXImmunic, Inc.

$138M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$998,000

Operating Income

-$53M

Net Income

-$52M

EPS (Diluted)

$-52.26

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$41M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$60M

Total Liabilities

$10M

Stockholders' Equity

$50M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$6,315	-100.0%
Gross Profit	-$998,000	-$2M	+44.6%
Operating Income	-$53M	-$41M	-27.6%
Net Income	-$52M	-$41M	-27.1%